Table 2.
Comparison of serum adiponectin levels after sex and BMI stratification.
| Cohort | Normal control (NC group, n = 40) | Diabetes without macroangiopathy (NM group, n = 90) | Diabetes with macroangiopathy (MA group, n = 83) | P value |
|---|---|---|---|---|
| Overall | 5.25 ± 1.99 (40) | 2.86 ± 1.35 (90)∗ | 1.89 ± 0.92 (83)∗# | <0.001 |
| Sex | ||||
| Male | 4.58 ± 1.87 (18) | 2.76 ± 1.14 (44)∗ | 1.54 ± 0.74 (38)∗# | <0.001 |
| Female | 5.80 ± 1.96 (22) | 2.95 ± 1.54 (46)∗ | 2.18 ± 0.97 (45)∗#† | <0.001 |
| P value | 0.052 | 0.508 | 0.001 | |
| BMI | ||||
| Normal BMI | 5.54 ± 1.82 (31) | 3.27 ± 1.61 (41)∗ | 2.00 ± 1.03 (35)∗# | <0.001 |
| Overweight or obese | 4.25 ± 2.33 (9)‡ | 2.51 ± 0.98 (49)∗‡ | 1.81 ± 0.84 (48)∗#‡ | <0.001 |
| P value | 0.023 | 0.011 | 0.042 |
∗Significantly different from the NC group. #Significantly different from the NM group. †Significantly different from the male group. ‡Significantly different from the normal BMI group. BMI: body mass index. Measurement data are presented as mean ± standard deviation or median (with interquartile ranges). The unit of the concentrations of serum adiponectin: mg/L.